Ilika advancing Goliath product development with placings (LON:IKA)

Ilika plc (LON:IKA) Chief Financial Officer Steve Boydell caught up with DirectorsTalk for an exclusive interview to discuss their successful institutional & retail placings, what the fund will be used for, total share allocation, deadline, and the excess application facility.

Q1: First off, congratulations on Ilika’s successful institutional and retail placings, I think your secured £21 million. Steve, what is the principal use of the funds?

A1: There’s three principle uses of the funds.

£10 million of the proceeds of the placing are expected to be used to fund the development of our large scale battery technology which is for a consumer appliance and electric vehicle applications, which we’ve codenamed Goliath. That’s to take it beyond conventional lithium-ion battery performance.

£5 million is expected to be invested in increasing the capacity of our Goliath pre-pilot line that we have here in Romsey, taking it from 1 kilowatt hour to 10 kilowatt hours, and that’s largely through increased automation of our processes.

Then the balance is to strengthen our balance sheet and provide additional working capital to support the Goliath product development.

Q2: How have you allowed retail investors to participate in the placing?

A2: So, retail investors have been able to participate through a £3 million retail offer by Primary Bid that actually closed on Friday last week, but also through a £3.7 million open offer. The circular for this was posted out to existing shareholders yesterday but it’s also available as a download from the investor section of our website.

Q3: What determined the total share allocation then in the placing for retail investors?

A3: So, the total of £6.7 million that we’ve made available to retail investors through the retail and open offers is the maximum that the company can offer without the need to issue a prospectus. That would have involved considerable extra costs and delays to the fundraising process, which is why we’ve elected to go this route.

Q4: When is the deadline for participating in the open offer?

A4: The deadline for the receipt of the completed application form along with payment is 11:00am on the 27th of July.

Q5: Now, do the open offer mentions a one to 52 entitlement? What happens if a retail investor would like to purchase more than they’re entitled in the placing?

A5: So, applications by shareholders will be satisfied in full up to their open offer entitlement so that 1 in 52, but shareholders can apply for more than that 1 in 52 through the excess application facility. So, if all of the open offer entitlements are not taken up by shareholders, Ilika will allocate shares up to the maximum 3.7 million allowed so those shareholders who’ve applied through this excess application facility.

Click to view all articles for the EPIC:
Or click to view the full company profile:
Facebook
Twitter
LinkedIn
Ilika plc

More articles like this

Ilika plc

Solid-state batteries: The future of power storage

The world of power storage is on the brink of a revolutionary shift, as solid-state batteries are poised to redefine the landscape of energy storage. With the increasing demand for renewable energy sources and the growing

Ilika plc

A closer look at Solid-State Batteries

As we stand on the brink of a new era in technology, the future seems to hold exciting possibilities. One such promising innovation is the solid-state battery, a technological marvel that is poised to revolutionize the

Ilika plc

Ilika AGM to be held on Wednesday 20 September 2023

Ilika plc (LON:IKA), a pioneer in solid state battery technology, has confirmed that the Annual Report and Accounts for the year ended 30 April 2023 and the Notice of the 2023 Annual General Meeting will be made available shortly

Ilika plc

What are solid-state batteries?

To understand what a solid-state battery is, we need to first look at existing battery technology first. Most modern EVs are equipped with Lithium-Ion batteries, with separators within its cells to keep their anodes and cathodes

Ilika plc

Ilika plc: Developing Solid-State Batteries

Ilika plc is a UK-based company that focuses on developing and commercializing innovative solid-state batteries. Their main products are the Stereax batteries, which are thin-film miniature solid-state batteries used to power implantable medical devices and industrial

Ilika plc

Cirtec and Ilika finalise Stereax battery manufacturing deal

Battery developer Ilika has signed a 10-year deal for Cirtec Medical to manufacture Stereax batteries in Lowell, Massachusetts. The two medtech suppliers announced their partnership on the millimeter-scale, solid-state batteries in January. Now, Ilika and Cirtec Medical

Ilika plc

Ilika signs 10-year manufacturing licence with Cirtec

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has announced that, further to its announcement on 16 January 2023, it has concluded contractual negotiations with Cirtec Medical, an industry-leading strategic outsourcing partner of complex medical devices

Ilika plc

Ilika posts turnover of £0.7 million in fiscal 2023

Romsey-based Ilika reported turnover of £0.7 million in its year to end-April, 2023 compared to £0.5 million in the year earlier period as the company continues to commercialise its Stereax miniature solid-state batteries for medical devices

Ilika plc

Ilika’s John Tinson interview with APCUK

Ilika plc (LON:IKA) is a pioneer in solid state battery technology enabling solutions for applications in Industrial IoT, MedTech, Electric Vehicles and Consumer Electronics.